The largest database of trusted experimental protocols

Trimethoprim sulfa

Manufactured by Inotiv

Trimethoprim Sulfa is a laboratory reagent used in chemical and biological research. It is a combination of two antimicrobial agents, trimethoprim and sulfamethoxazole, commonly known as co-trimoxazole. This product is used for various applications in research settings, such as cell culture, microbiology, and biochemistry experiments.

Automatically generated - may contain errors

4 protocols using trimethoprim sulfa

1

Neonatal Hematopoietic Cell Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For non-sorted transplants, the embryo equivalent used for each timepoint is as follows: ≥4 ee for e9.5, ≤3 ee for e10.5, and ≤1 ee for e11.5. For all transplants, single cell suspensions were resuspended in 50–70 μL FACS buffer for injection with defined numbers of adult helper BM added. For neonatal transplants, cells were injected into the facial vein of sublethally irradiated (180–200 Rads; XRAD 320, Precision X-ray) P1-P4 NSG recipients. Nursing NSG mothers were fed an antibiotic chow of Trimethoprim Sulfa (Uniprim, Envigo) for 4 weeks post transplant to prevent bacterial infections. For secondary transplantation into adult recipients, recipient C57BL/6 mice were conditioned with 800 Rads, anesthetized by isoflurane, and retro-orbitally injected with 1–2 million whole BM harvested from primary recipients. For peripheral blood analysis, blood was obtained from the tail vein of transplanted mice at various timepoints, and red blood cells were depleted using ACK lysis buffer. For BM analysis, BM was harvested from tibias and femurs by flushing with ice-cold FACS buffer followed by ACK lysis and filtration. Cells were stained with lineage antibodies and analyzed on the BD FACS-Aria II. FlowJo software (Tree Star) was used for data analysis.
+ Open protocol
+ Expand
2

Transplantation and Analysis of HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Defined numbers of HSCs (as indicated in each experiment) were transplanted by retro‐orbital injection into lethally‐irradiated isoflurane‐anesthetized recipients alongside helper BM from congenically distinguishable C57BL/6 mice. Lethal doses of x‐ray irradiation were 800 Rads for single dose, or 950 Rads split dose (XRAD 320, Precision X‐ray, North Branford, CT). Transplanted recipients were fed an antibiotic chow of Trimethoprim Sulfa (Uniprim, Envigo, East Millstone, NJ) for 4 weeks post transplantation to prevent potential bacterial infections. For peripheral blood analysis, blood was obtained from the tail vein of transplanted mice at various time points, and red blood cells were depleted using ACK lysis buffer. For BM analysis, BM was harvested from tibias and femurs by flushing with ice‐cold FACS buffer followed by ACK lysis and filtration. Cells were stained with lineage antibodies and analyzed on the BD FACS‐Aria II. For a comprehensive list of markers used for identification of each population, refer to Table S2 (“Marker definitions of populations analyzed”) in Supporting Information. FlowJo software (Tree Star) was used for data analysis.
+ Open protocol
+ Expand
3

Lethal Irradiation and Hematopoietic Stem Cell Transplant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted cells were cultured for 16 h in 37°C and 5% CO2. A well of either FLU‐treated or Vehicle‐treated TM5 cells was combined 1:1 with a well containing vehicle‐treated mTmG cells for a total of 2 × 104 KLS donor sorted cells per recipient. These cells were transplanted via retro‐orbital injection into lethally‐irradiated isoflurane‐anesthetized gender matched C57BL/6 recipients. Lethal dose of X‐ray irradiation was 850 cGy single dose (XRAD 320, Precision X‐ray, North Branford, CT). Transplanted recipients were fed an antibiotic chow of Trimethoprim Sulfa (Uniprim, Envigo, East Millstone, NJ) for 3 weeks to prevent potential bacterial infections. For peripheral blood analysis, blood was obtained from the tail vein of transplanted mice at various time points, and red blood cells were depleted using ACK lysis buffer. For BM analysis, BM was harvested from tibias and femurs by flushing with ice‐cold FACS buffer (PBS with 2% fetal bovine serum) followed by ACK lysis and filtration. BM HSC population is defined as single cell, PI, Ter119, CD27+, c‐kit+, Sca1+, CD150+, cells with donor cells expressing CFP. Cells were analyzed on the BD Fortessa. Exclusion criteria include recipient mice without engraftment (chimerism below 1%), or recipients that died prior to analysis. FlowJo software (Tree Star) was used for data analysis.
+ Open protocol
+ Expand
4

Generating Immune-Labeled 5xFAD Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate 5xFAD mice with labeled peripheral immune cells, fluorescently-labeled BM (GFP, RFP or CFP) was transplanted into neonatal (postnatal day 1, P1) 5xFAD+/− (5X) and 5xFAD−/− (WT) littermates. P1 5X and WT littermates were given ≤3.5 Gy (350 Rads) dose of X-ray irradiation (XRAD 320, Precision X-ray). Donor bone marrow was first ckit-enriched by staining with microbead-conjugated ckit antibodies (Miltenyi) and enriched using the positive selection (“possel”) setting on an autoMACS (Miltenyi). Each pup was given up to 200,000 ckit+ BM cells from RFP mice via facial vein injection. Pups were placed back with the mother, who was fed an antibiotic chow of Trimethoprim Sulfa (Uniprim, Envigo). After weaning, the recipients were switched to regular chow and genotyped with ear or tail snips. Chimerism was measured through tail vein bleeds at 5 weeks of age and immediately before harvest and confirmed by BM HSC analysis upon tissue harvesting. 5X and WT recipients with similar levels of donor chimerism were paired for comparison.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!